🔎 Trials Near Me

Akèy › Maladi Crohn › Kansas › Kansas City

Etid klinik pou Maladi Crohn nan Kansas City, KS

6 etid pou Maladi Crohn ap chèche patisipan nan sit nan ak bò kote Kansas City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Ap rekriteFaz 1
  • University of Kansas Cancer Center, Kansas City
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT03816345

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Ap rekriteFaz 3
  • University of Kansas Medical Center ( Site 5091), Kansas City
Laj 16 a 80 · Tout sèks · Mizajou Oct 2, 2026 · NCT06430801

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

Ap rekriteFaz 2
  • University of Kansas Medical Center, Kansas City
Laj 18 a 75 · Tout sèks · Mizajou Sep 25, 2026 · NCT06233461

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Ap rekriteFaz 3
  • University of Kansas Medical Center-Site Number: 8400110, Kansas City
Laj 16 a 80 · Tout sèks · Mizajou Sep 23, 2026 · NCT07184931

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Ap rekriteFaz 4
  • University of Kansas Medical Center, Kansas City
Laj 18 a 70 · Tout sèks · Mizajou Sep 9, 2026 · NCT06045754

A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

Ap rekriteFaz 2
  • Investigational Site Number: 8400006, Kansas City
Laj 18 a 75 · Tout sèks · Mizajou Mar 27, 2026 · NCT06958536

Etid Maladi Crohn nan lòt vil

Lòt etid nan Kansas City

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.